FORM OF UNDERWRITING AGREEMENT BIOLASE, INC.Underwriting Agreement • December 12th, 2022 • Biolase, Inc • Dental equipment & supplies • New York
Biolase, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule I hereto (the “Underwriters” or each, an “Underwriter”) an aggregate of (x) [•] units of the Company (each a “Unit” and collectively, the “Units”), with each Unit consisting of (i) one share (each a “Firm Share” and collectively, the “Firm Share”) of common stock, par value $0.001 per share, of the Company (the “Common Stock”) and (ii) one common stock purchase warrant of the Company (each a “Firm Warrant” and collectively, the “Firm Warrants”), with each Firm Warrant exercisable to purchase one share of Common Stock (the “Firm Warrant Shares”), at an exercise price of $[•] per share, subject to adjustment therein, and (y) [•] pre-funded units of the Company (each a “Pre-Funded Unit” and collectively, the “Pre-Funded Units”), with each Pre-Funded Unit consisting of one pre-funded common stock purchase warrant of the Company (each a “Firm Pre-Funded Warrant” an
